Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next ...
Emergent BioSolutions, Rocketvax announce investment agreement
Emergent BioSolutions (EBS) and Rocketvax announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets, ...
The Nassau Guardian5d
More transparency needed over SpaceX deal, Carey says
The “lack of transparency” surrounding the Davis administration’s agreement with SpaceX to allow Falcon 9 booster landings in ...
The Manila Times6d
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading ...